Published in Pediatr Cardiol on September 13, 2007
Cardiac sympathetic hypo-innervation in familial dysautonomia. Clin Auton Res (2008) 0.87
Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation (1995) 2.31
Survival in familial dysautonomia: Impact of early intervention. J Pediatr (2002) 1.98
Pacemakers in patients with familial dysautonomia--a review of experience with 20 patients. Clin Auton Res (2005) 1.54
Familial dysautonomia. Muscle Nerve (2004) 1.40
Deficient sympathetic nervous response in familial dysautonomia. N Engl J Med (1976) 1.12
Electrocardiographic repolarization abnormalities in familial dysautonomia: an indicator of cardiac autonomic dysfunction. Clin Auton Res (1999) 0.83
Electrocardiographic measures and heart rate variability in patients with familial dysautonomia. Cardiology (1997) 0.83
Highly abnormal thermotests in familial dysautonomia suggest increased cardiac autonomic risk. J Neurol Neurosurg Psychiatry (1998) 0.81
Abnormalities of the corrected QT interval in familial dysautonomia: an indicator of autonomic dysfunction. J Pediatr (1993) 0.81
Cardiac pacing in patients with familial dysautonomia--there is nothing simple about sudden death. Clin Auton Res (2005) 0.77
Transient third-degree atrioventricular block in a 4-year-old child with familial dysautonomia. Pediatr Cardiol (1992) 0.75
Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease. J Am Soc Nephrol (2007) 2.73
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med (2002) 2.44
Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol (2012) 2.10
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation (2004) 1.82
Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: need for agents to target antibody-secreting plasma cells. Mol Genet Metab (2012) 1.79
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa. Mol Genet Metab (2012) 1.58
Segmental neurofibromatosis in childhood. Am J Med Genet A (2003) 1.53
Fanconi-Bickel syndrome: report of life history and successful pregnancy in an affected patient. Am J Med Genet A (2011) 1.53
NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Report of the writing committee. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol (2002) 1.47
Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood (2005) 1.41
The genetics of tethered cord syndrome. Am J Med Genet A (2005) 1.40
Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients. Semin Hematol (2004) 1.36
Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1. Genet Med (2009) 1.34
Amiodarone therapy for drug-refractory fetal tachycardia. Circulation (2004) 1.29
Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet A (2003) 1.28
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol (2012) 1.27
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2015) 1.26
Late reoperations for Fontan patients: state of the art invited review. Eur J Cardiothorac Surg (2008) 1.25
Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements. Eur J Pediatr (2003) 1.16
Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile pompe disease: a step towards improving the efficacy of ERT. PLoS One (2013) 1.14
Guidance on the use of miglustat for treating patients with type 1 Gaucher disease. Am J Hematol (2005) 1.13
Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma. Ann Neurol (2014) 1.12
J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes. Ann Thorac Surg (2007) 1.07
Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment. J Inherit Metab Dis (2012) 1.06
Individualization of long-term enzyme replacement therapy for Gaucher disease. Genet Med (2005) 1.02
Conversion of the failed Fontan circulation. Cardiol Young (2006) 1.01
Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv Syst (2009) 0.97
Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase. Am J Hematol (2013) 0.97
The beneficial effects of total cavopulmonary conversion and arrhythmia surgery for the failed Fontan. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2002) 0.95
Arrhythmia surgery in association with complex congenital heart repairs excluding patients with fontan conversion. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2003) 0.94
Surgical advances in the treatment of adults with congenital heart disease. Curr Opin Pediatr (2009) 0.93
Knowledge without truth: screening for complications of neurofibromatosis type 1 in childhood. Am J Med Genet A (2004) 0.90
Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoring. Eur J Pediatr (2003) 0.90
Extracardiac versus intra-atrial lateral tunnel fontan: extracardiac is better. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2011) 0.88
Development of a newborn screening follow-up algorithm for the diagnosis of isobutyryl-CoA dehydrogenase deficiency. Genet Med (2007) 0.87
Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry. Genet Med (2013) 0.87
Growth hormone excess in children with neurofibromatosis type 1-associated and sporadic optic pathway tumors. J Pediatr (2010) 0.84
Reduced elastogenesis: a clue to the arteriosclerosis and emphysematous changes in Schimke immuno-osseous dysplasia? Orphanet J Rare Dis (2012) 0.84
Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing. Am J Med Genet A (2009) 0.84
An integrated approach to the care of adult patients with prior atriopulmonary Fontan surgery. J Pediatr Health Care (2008) 0.82
Prevalence of type 1 Gaucher disease in the United States. Arch Intern Med (2008) 0.81
Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann-Pick type B. Pediatr Blood Cancer (2007) 0.81
Heart transplantation for the failing Fontan. Ann Thorac Surg (2013) 0.81
A newborn girl with hypotonia and respiratory failure. Pediatr Ann (2007) 0.80
Orbital optic nerve gliomas in children with neurofibromatosis type 1. J AAPOS (2006) 0.80
Dual-chamber epicardial pacing in neonates with congenital heart block. J Thorac Cardiovasc Surg (2007) 0.78
Follow-up of patients with short-chain acyl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase deficiencies identified through newborn screening: one center's experience. Genet Med (2012) 0.78
Vitamin B12 status, methylmalonic acidemia, and bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr (2009) 0.78
Gustatory flushing (auriculotemporal nerve syndrome) in children with neurofibromatosis type 1 and facial plexiform neurofibromas. J Pediatr (2011) 0.78
Genetics professionals' opinions of whole-genome sequencing in the newborn period. J Genet Couns (2014) 0.78
Location of accessory connection in infants presenting with supraventricular tachycardia in utero: clinical correlations. Am J Perinatol (2003) 0.78
A 14-year-old boy with pain in hands and feet. Pediatr Ann (2009) 0.77
Late sinus and atrial tachycardia after pediatric heart transplantation might predict poor outcome. Pediatr Cardiol (2010) 0.77
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2015) 0.77
Device management of arrhythmias after Fontan conversion. J Thorac Cardiovasc Surg (2009) 0.76
Evolving anatomic and electrophysiologic considerations associated with Fontan conversion. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2007) 0.76
Neuroimaging findings in children with rare or novel de novo chromosomal anomalies. Birth Defects Res A Clin Mol Teratol (2008) 0.76
Maze procedure in single ventricle patients. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2008) 0.76
Arrhythmia surgery in patients with and without congenital heart disease. Ann Thorac Surg (2008) 0.75
Surgery for arrhythmias in children. Int J Cardiol (2004) 0.75
Atrioventricular valve procedures with repeat fontan operations: influence of valve pathology, ventricular function, and arrhythmias on outcome. Ann Thorac Surg (2005) 0.75
Storage and use of Newborn Screening Blood Specimens for Research: Assessing Public Opinion in Illinois. J Genet Couns (2014) 0.75
Episodic myoglobinuria in a primary gamma-sarcoglycanopathy. Neuromuscul Disord (2010) 0.75
Neurofibromatosis-1 in childhood. Adv Dermatol (2004) 0.75
A 5-year-old girl with developmental delay. Pediatr Ann (2007) 0.75
Case challenges in genetics. Pediatr Ann (2007) 0.75
Optimal initial palliation for patients with functionally univentricular hearts. World J Pediatr Congenit Heart Surg (2012) 0.75
Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana. Heart Rhythm (2005) 0.75
Growth Hormone Excess in Children with Optic Pathway Tumors Is a Transient Phenomenon. Horm Res Paediatr (2016) 0.75